StockData
CLCSOTCPharmaceutical PreparationsFiscal year ends December 31

Cell Source, Inc.

Financials through Q1 FY2025, quarter ended Mar 31, 2025Last filing: 10-Q on May 14, 2026
$0.49−0.00 (-0.01%)

Close on Oct 19, 2026

Market cap
$21.99M
P/E (TTM)
–
Dividend yield
–

Cell Source, Inc. cash flow statement

Ratios

Latest available, balances at Mar 31, 2025

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2024
26.4%

Financial strength

Current ratio
–
Debt to equity
–
Debt to assets
–
Cash to current liabilities
–

Valuation

P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–